{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:02:22Z","timestamp":1768716142485,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"crossref","award":["2012011038-4, 201801D121347"],"award-info":[{"award-number":["2012011038-4, 201801D121347"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["201701D121165"],"award-info":[{"award-number":["201701D121165"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Research Program of Fenyang College of Shanxi Medical University","award":["2016D10"],"award-info":[{"award-number":["2016D10"]}]},{"name":"Intramural Research Program of Fenyang College of Shanxi Medical University","award":["2016D12"],"award-info":[{"award-number":["2016D12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00432-021-03691-7","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T02:02:41Z","timestamp":1623808961000},"page":"267-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aberrant expression and genetic alteration of c-MYC in anaplastic large cell lymphoma"],"prefix":"10.1007","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4292-2340","authenticated-orcid":false,"given":"Zhenwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfeng","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yirong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoai","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"3691_CR1","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/leu.2017.103","volume":"31","author":"V Atsaves","year":"2017","unstructured":"Atsaves V, Tsesmetzis N, Chioureas D et al (2017) PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma. Leukemia 31:1633\u20131637. https:\/\/doi.org\/10.1038\/leu.2017.103","journal-title":"Leukemia"},{"key":"3691_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey SC, Tong L, Li Y et al (2016) MYC regulates the antitumor immune response through CD47 and PD-L1. Science 352:227\u2013231. https:\/\/doi.org\/10.1126\/science.aac9935","journal-title":"Science"},{"key":"3691_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1365-2362.2011.02585.x","volume":"42","author":"Z Chen","year":"2012","unstructured":"Chen Z, Wang J, Zhang H et al (2012) Topo II\u03b1 gene alterations correlated with survival in patients with diffuse large B-cell lymphoma. Eur J Clin Invest 42:310\u2013320. https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02585.x","journal-title":"Eur J Clin Invest"},{"key":"3691_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV (2012) MYC on the path to cancer. Cell 149:22\u201335. https:\/\/doi.org\/10.1016\/j.cell.2012.03.003","journal-title":"Cell"},{"key":"3691_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","volume":"117","author":"AL Feldman","year":"2011","unstructured":"Feldman AL, Dogan A, Smith DI et al (2011) Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood 117:915\u2013919. https:\/\/doi.org\/10.1182\/blood-2010-08-303305","journal-title":"Blood"},{"key":"3691_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/gcc.22104","volume":"52","author":"AL Feldman","year":"2013","unstructured":"Feldman AL, Vasmatzis G, Asmann YW et al (2013) Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma. Genes Chromosomes Cancer 52:1097\u20131102. https:\/\/doi.org\/10.1002\/gcc.22104","journal-title":"Genes Chromosomes Cancer"},{"key":"3691_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.critrevonc.2012.06.004","volume":"85","author":"AJ Ferreri","year":"2013","unstructured":"Ferreri AJ, Govi S, Pileri SA et al (2013) Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol 85:206\u2013215. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.06.004","journal-title":"Crit Rev Oncol Hematol"},{"key":"3691_CR8","doi-asserted-by":"publisher","first-page":"e77375","DOI":"10.1371\/journal.pone.0077375","volume":"8","author":"F Helm","year":"2013","unstructured":"Helm F, Kammertoens T, Lehmann FM et al (2013) Targeting c-MYC with T-cells. PLoS ONE 8:e77375. https:\/\/doi.org\/10.1371\/journal.pone.0077375","journal-title":"PLoS ONE"},{"key":"3691_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-0609.1997.tb00955.x","volume":"59","author":"M Hermann","year":"1997","unstructured":"Hermann M, Scholman HJ, Marafioti T et al (1997) Differential expression of apoptosis, Bcl-x and c-Myc in normal and malignant lymphoid tissues. Eur J Haematol 59:20\u201330. https:\/\/doi.org\/10.1111\/j.1600-0609.1997.tb00955.x","journal-title":"Eur J Haematol"},{"key":"3691_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/modpathol.3800299","volume":"18","author":"R Kansal","year":"2005","unstructured":"Kansal R, Sait SN, Block AW et al (2005) Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology. Mod Pathol 18:235\u2013243. https:\/\/doi.org\/10.1038\/modpathol.3800299","journal-title":"Mod Pathol"},{"key":"3691_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1043\/2010-0507-RAR.1","volume":"135","author":"MC Kinney","year":"2011","unstructured":"Kinney MC, Higgins RA, Medina EA (2011) Anaplastic large cell lymphoma: twenty-five years of discovery. Arch Pathol Lab Med 135:19\u201343. https:\/\/doi.org\/10.1043\/2010-0507-RAR.1","journal-title":"Arch Pathol Lab Med"},{"key":"3691_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","volume":"149","author":"K Klapproth","year":"2010","unstructured":"Klapproth K, Wirth T (2010) Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol 149:484\u2013497. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08159.x","journal-title":"Br J Haematol"},{"key":"3691_CR13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","volume":"363","author":"EL Kwak","year":"2010","unstructured":"Kwak EL, Bang YJ, Camidge DR et al (2010) Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 363:1693\u20131703. https:\/\/doi.org\/10.1056\/NEJMoa1006448","journal-title":"N Engl J Med"},{"key":"3691_CR14","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/MPH.0b013e3182815046","volume":"35","author":"X Liang","year":"2013","unstructured":"Liang X, Branchford B, Greffe B et al (2013) Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. J Pediatr Hematol Oncol 35:e209\u2013e213. https:\/\/doi.org\/10.1097\/MPH.0b013e3182815046","journal-title":"J Pediatr Hematol Oncol"},{"key":"3691_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.humpath.2020.11.002","volume":"108","author":"KA Lyapichev","year":"2020","unstructured":"Lyapichev KA, Tang G, Li S et al (2020) MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma. Hum Pathol 108:22\u201331. https:\/\/doi.org\/10.1016\/j.humpath.2020.11.002","journal-title":"Hum Pathol"},{"key":"3691_CR16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nrc2231","volume":"8","author":"N Meyer","year":"2008","unstructured":"Meyer N, Penn LZ (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8:976\u2013990. https:\/\/doi.org\/10.1038\/nrc2231","journal-title":"Nat Rev Cancer"},{"key":"3691_CR17","first-page":"397","volume":"5","author":"P Minoo","year":"2012","unstructured":"Minoo P, Wang HY (2012) ALK-immunoreactive neoplasms. Int J Clin Exp Pathol 5:397\u2013410","journal-title":"Int J Clin Exp Pathol"},{"key":"3691_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ajh.21887","volume":"86","author":"H Moritake","year":"2011","unstructured":"Moritake H, Shimonodan H, Marutsuka K et al (2011) C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17\/C-MYC. Am J Hematol 86:75\u201378. https:\/\/doi.org\/10.1002\/ajh.21887","journal-title":"Am J Hematol"},{"key":"3691_CR19","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB et al (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science 263:1281\u20131284. https:\/\/doi.org\/10.1126\/science.8122112","journal-title":"Science"},{"key":"3691_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar ER, Jaffe ES, Said JW et al (2014) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124:1473\u20131480. https:\/\/doi.org\/10.1182\/blood-2014-04-571091","journal-title":"Blood"},{"key":"3691_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1365-2141.2005.05808.x","volume":"131","author":"SL Perkins","year":"2005","unstructured":"Perkins SL, Pickering D, Lowe EJ et al (2005) Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: A genetic and pathological correlation. Br J Haematol 131:624\u2013627. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05808.x","journal-title":"Br J Haematol"},{"key":"3691_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood-2005-05-2125","volume":"107","author":"R Piva","year":"2006","unstructured":"Piva R, Chiarle R, Manazza AD et al (2006) Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood 107:689\u2013697. https:\/\/doi.org\/10.1182\/blood-2005-05-2125","journal-title":"Blood"},{"key":"3691_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jcp.10472","volume":"199","author":"K Pulford","year":"2004","unstructured":"Pulford K, Morris SW, Turturro F (2004) Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol 199:330\u2013358. https:\/\/doi.org\/10.1002\/jcp.10472","journal-title":"J Cell Physiol"},{"key":"3691_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0002-9440(10)64248-4","volume":"161","author":"EA Raetz","year":"2002","unstructured":"Raetz EA, Perkins SL, Carlson MA et al (2002) The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas. Am J Pathol 161:875\u2013883. https:\/\/doi.org\/10.1016\/S0002-9440(10)64248-4","journal-title":"Am J Pathol"},{"key":"3691_CR25","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1200\/JCO.2012.42.2345","volume":"30","author":"D Sibon","year":"2012","unstructured":"Sibon D, Fournier M, Briere J et al (2012) Long-term outcome of adults with systemic anaplastic large cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte trials. J Clin Oncol 30:3939\u20133946. https:\/\/doi.org\/10.1200\/JCO.2012.42.2345","journal-title":"J Clin Oncol"},{"key":"3691_CR26","doi-asserted-by":"publisher","first-page":"E638","DOI":"10.3390\/cancers12030638","volume":"12","author":"A Strippoli","year":"2020","unstructured":"Strippoli A, Cocomazzi A, Basso M et al (2020) c-MYC expression is a possible keystone in the colorectal cancer resistance to EGFR inhibitors. Cancers (basel) 12:E638. https:\/\/doi.org\/10.3390\/cancers12030638","journal-title":"Cancers (basel)"},{"key":"3691_CR27","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2016b) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon","edition":"4"},{"key":"3691_CR28","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA et al (2016a) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"3691_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fonc.2012.00041","volume":"2","author":"F Tabb\u00f3","year":"2012","unstructured":"Tabb\u00f3 F, Barreca A, Piva R et al (2012) ALK signaling and target therapy in anaplastic large cell lymphoma. Front Oncol 2:41. https:\/\/doi.org\/10.3389\/fonc.2012.00041","journal-title":"Front Oncol"},{"key":"3691_CR30","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3324\/haematol.2013.086173","volume":"98","author":"A Valera","year":"2013","unstructured":"Valera A, L\u00f3pez-Guillermo A, Cardesa-Salzmann T et al (2013) MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Haematologica 98:1554\u20131562. https:\/\/doi.org\/10.3324\/haematol.2013.086173","journal-title":"Haematologica"},{"key":"3691_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3324\/haematol.2009.014761","volume":"95","author":"K Van Roosbroeck","year":"2010","unstructured":"Van Roosbroeck K, Cools J, Dierickx D et al (2010) ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions. Haematologica 95:509\u2013513. https:\/\/doi.org\/10.3324\/haematol.2009.014761","journal-title":"Haematologica"},{"key":"3691_CR32","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","volume":"120","author":"G Vasmatzis","year":"2012","unstructured":"Vasmatzis G, Johnson SH, Knudson RA et al (2012) Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 120:2280\u20132289. https:\/\/doi.org\/10.1182\/blood-2012-03-419937","journal-title":"Blood"},{"key":"3691_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1182\/blood-2014-08-594507","volume":"125","author":"A Weilemann","year":"2015","unstructured":"Weilemann A, Grau M, Erdmann T et al (2015) Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma. Blood 125:124\u2013132. https:\/\/doi.org\/10.1182\/blood-2014-08-594507","journal-title":"Blood"},{"key":"3691_CR34","doi-asserted-by":"publisher","first-page":"E138","DOI":"10.3390\/cancers9100138","volume":"9","author":"MT Werner","year":"2017","unstructured":"Werner MT, Zhang Q, Wasik MA (2017) From pathology to precision medicine in anaplastic large cell lymphoma expressing anaplastic lymphoma kinase (ALK+ ALCL). Cancers (basel) 9:E138. https:\/\/doi.org\/10.3390\/cancers9100138","journal-title":"Cancers (basel)"},{"key":"3691_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-016-0349-z","volume":"9","author":"C Wu","year":"2016","unstructured":"Wu C, Zhang HF, Gupta N et al (2016) A positive feedback loop involving the Wnt\/\u03b2-catenin\/MYC\/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma. J Hematol Oncol 9:120. https:\/\/doi.org\/10.1186\/s13045-016-0349-z","journal-title":"J Hematol Oncol"},{"key":"3691_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hon.991","volume":"29","author":"HW Zhang","year":"2011","unstructured":"Zhang HW, Chen ZW, Li SH et al (2011) Clinical significance and prognosis of MYC translocation in diffuse large B-cell lymphoma. Hematol Oncol 29:185\u2013189. https:\/\/doi.org\/10.1002\/hon.991","journal-title":"Hematol Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03691-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03691-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03691-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T13:05:52Z","timestamp":1641906352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03691-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3691"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03691-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"4 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Medical Ethics Committee of Shanxi Tumor Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}